BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//CITI Program - ECPv6.17.3//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:CITI Program
X-ORIGINAL-URL:https://about.citiprogram.org
X-WR-CALDESC:Events for CITI Program
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20270314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20271107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260728T083000
DTEND;TZID=America/New_York:20260728T160000
DTSTAMP:20260624T173716Z
CREATED:20260624T173716Z
LAST-MODIFIED:20260624T173716Z
UID:62389-1785227400-1785254400@about.citiprogram.org
SUMMARY:ICH S7A and New Approach Methodologies (NAMs) in Safety Pharmacology
DESCRIPTION:The U.S. Food and Drug Administration (FDA)\, in collaboration with the Health and Environmental Sciences Institute (HESI) and the Safety Pharmacology Society (SPS)\, will host a hybrid public workshop titled “ICH S7A and New Approach Methodologies (NAMs) in Safety Pharmacology” on July 28\, 2026. This one-day event will bring together representatives from regulatory agencies and industry to discuss potential revisions to the International Council for Harmonisation (ICH) S7A guideline. The workshop is intended to gather stakeholder perspectives\, explore scientific considerations\, and support the development of a cohesive framework for integrating new approach methodologies (NAMs) into safety pharmacology. \nThe meeting will focus on sharing real-world experiences and fostering dialogue around the application of NAMs\, including their benefits\, limitations\, and implementation timelines. Discussions will also address the evolving regulatory landscape\, particularly efforts to reduce reliance on animal testing and evaluate alternative models. \nWorkshop objectives: \n\nEstablish a shared\, cross-regional understanding of NAMs in safety pharmacology\nClarify regulatory opportunities and constraints for NAM inclusion in S7A\nDefine clear\, discipline-specific NAM use cases relevant to S7A\nDevelop actionable recommendations and next steps to support NAM integration into S7A\n\nWhile the workshop will not result in immediate changes to regulatory guidance\, insights generated during the event are expected to inform future policy considerations and contribute to the advancement of safety evaluation practices. \nThis event will be held both in-person and online. \nVisit the event page for more information.
URL:https://about.citiprogram.org/event/ich-s7a-and-new-approach-methodologies-nams-in-safety-pharmacology/
LOCATION:FDA White Oak Campus: The Great Room\, Building 31\, 10903 New Hampshire Avenue\, Silver Spring\, MD\, 20993\, United States
ATTACH;FMTTYPE=image/png:https://about.citiprogram.org/wp-content/uploads/2025/04/fda-logo.png
END:VEVENT
END:VCALENDAR